Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40763641	pd-solut	— (—)	79	304	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic kidney disease

+∞

81.17

3.9

0.0

—

Dialysis, with operation codes

+∞

80.41

3.9

0.0

—

Dialysis

+∞

79.92

3.7

0.0

—

Renal failure

+∞

78.52

3.9

0.0

—

Care involving dialysis

+∞

74.26

3.8

0.0

—

Heart failure, not strict

37.27

64.52

4.5

2.0

—

Other dialysis

+∞

63.16

3.8

0.0

—

Glomerular diseases

73.18

51.05

3.2

9.1

—

Persons encountering health services for specific procedures and health care

67.16

47.94

3.9

5.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

17.89

47.76

4.6

2.1

—

Acute peritonitis

+∞

47.02

4.3

0.0

—

ILD medications: immunosuppressive drugs

17.83

46.89

4.3

3.9

—

Kidney transplant status

+∞

41.82

4.0

0.0

—

Glomerular disorders in diseases classified elsewhere

72.47

37.95

3.6

11.3

—

Other bacterial diseases

11.97

36.17

4.1

3.6

—

Explicit Sepsis

18.00

36.13

4.5

3.4

—

Septicaemia

15.51

32.56

4.6

3.3

—

Hypertensive diseases

45.33

32.53

4.3

4.0

—

Hypertension

45.32

32.53

4.3

4.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

9.63

31.08

4.1

3.6

—

Metabolic disorders

12.13

31.01

4.8

3.5

—

Other septicaemia

15.61

30.76

4.7

3.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

9.84

29.90

4.3

3.4

—

Bacterial Sepsis

14.67

29.14

4.4

3.1

—

Implicit bacterial Sepsis

17.65

28.94

4.7

1.9

—

Secondary hypertension

+∞

28.05

4.2

0.0

—

Insulin, fast-acting

11.16

27.51

3.4

5.7

—

First line medication for Crohn's disease

9.44

27.36

4.5

3.5

—

Implicit Sepsis

10.58

27.26

4.4

3.9

—

Bacterial infection, other or unspecified

13.54

27.16

3.1

3.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

9.68

27.12

4.2

—

Type 1 diabetes

13.89

27.01

3.6

5.6

—

Insulin, combination of fast acting with intermediate-acting or long-acting

9.52

26.19

3.3

5.1

—

ILD medications

8.95

26.00

4.5

3.4

—

Insulin, fast-acting or short human

10.01

25.55

3.4

5.3

—

Aplastic and other anaemias

12.49

24.69

3.8

4.5

—

Condition for Implicit Sepsis (Organ dysfunction codes)

9.50

24.54

4.4

4.1

—

L04AA Selective immunosuppressants

42.95

24.53

4.2

4.9

—

Insulin medication

9.13

24.48

3.3

4.4

—

Diabetic nephropathy, excluding more controls

50.31

23.87

3.4

8.4

—

Diabetic nephropathy

37.21

23.75

3.4

5.9

—

Type 1 diabetes, wide definition

12.79

23.67

3.8

5.6

—

Diabetic retinopathy, strict definition

16.81

23.06

3.5

4.5

—

Other disorders of kidney and ureter

54.27

23.04

1.7

2.6

—

Atherosclerosis, excluding cerebral and coronary sclerosis

15.33

22.83

3.3

4.2

—

Type 1 diabetes, wide definition, subgroup 1

12.95

22.80

4.0

5.8

—

Insulin, intermediate and long-acting

9.14

22.08

3.6

5.2

—

Preparatory care for dialysis

+∞

21.93

3.2

0.0

—

Hypertension, essential

37.71

21.91

4.0

4.6

—

Acute renal failure

+∞

21.88

3.0

0.0

—

Intestinal infectious diseases

7.17

21.30

4.3

3.7

—

Azathioprine

16.40

21.11

5.4

2.4

—

Sub-endpoint used in defining T1D endpoints

9.47

21.00

3.6

5.7

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

9.72

20.86

4.0

—

9.72

20.86

4.0

—

Peripheral artery disease

12.35

20.55

3.3

6.1

—

Other diseases of hard tissues of teeth

10.07

20.51

3.6

4.6

—

Disorders of other endocrine glands

9.12

20.43

3.5

4.7

—

Erysipelas

11.16

19.85

4.0

—

Dental caries

28.66

19.50

2.2

7.7

—

Diseases of pulp and periapical tissues

15.47

19.34

2.5

6.7

—

Dependence on enabling machines and devices, not elsewhere classified

+∞

18.86

5.2

0.0

—

Endocrine, nutritional and metabolic diseases

26.30

18.41

5.3

2.5

—

Hyperlipidaemia, other/unspecified

14.64

18.20

4.4

2.8

—

Statin medication

21.03

17.46

5.4

2.8

—

Fever of other and unknown origin

9.74

17.46

2.7

3.2

—

Diseases of arteries, arterioles and capillaries

7.75

17.14

3.1

6.1

—

Insulin, fast-acting (human)

15.03

16.75

4.9

9.1

—

Gout, FINNGEN

15.02

16.75

6.7

5.3

—

Codes for special purposes

8.15

16.61

4.8

3.5

—

Other retinal disorders

7.00

16.36

3.7

4.8

—

Any reimbursement code in KELA

+∞

16.36

6.1

0.0

—

All pneumoniae

5.72

16.12

4.0

—

Disorders of choroid and retina

6.60

16.00

3.5

4.9

—

Heart failure and antihypertensive medication

+∞

15.86

6.2

0.0

—

Complications of surgical and medical care, not elsewhere classified

6.01

15.64

3.4

4.6

—

Pneumonia, organism unspecified

5.90

15.44

4.0

—

Influenza and pneumonia

5.59

15.43

4.0

3.9

—

Type 2 diabetes, wide definition

7.70

15.34

3.7

4.8

—

Covid-19 confirmed case

9.48

15.20

4.4

3.5

—

Inflammatory bowel disease treatment related agents

5.39

15.18

4.7

3.1

—

Pneumonias (Asthma/COPD co-morbidities)

5.44

14.95

3.9

4.0

—

Provisional assignment of new diseases of uncertain etiology

7.50

14.81

4.9

3.4

—

Diseases of oral cavity, salivary glands and jaws

7.44

14.65

3.5

4.6

—

Certain infectious and parasitic diseases

8.45

14.62

5.3

3.4

—

Dentinal caries

24.90

14.62

2.0

8.4

—

Chronic periodontitis

36.09

14.42

3.0

8.8

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5.70

14.29

4.7

3.6

—

All-cause Heart Failure

7.93

13.96

5.7

2.1

—

Diabetes mellitus

5.97

13.84

3.7

4.2

—

Other heart diseases, wide

5.82

13.78

4.6

3.4

—

Heart failure, strict

7.54

13.44

5.7

2.0

—

ILD medications: azathioprine

25.77

13.34

5.4

2.9

—

Heart failure,strict

17.64

13.30

5.7

2.1

—

Persons encountering health services in other circumstances, wide

5.35

13.28

4.7

3.6

—

Other and unspecified anaemias

8.66

13.22

3.9

4.5

—

Other anaemias

8.64

13.18

3.9

4.5

—

Gout

10.53

12.96

6.7

4.5

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4.95

12.85

4.0

—

Other disorders of skin and subcutaneous tissue

6.30

12.85

3.0

5.0

—

Polyarthropathies

5.98

12.66

5.5

3.7

—

Diabetes, varying definitions

5.59

12.64

3.6

4.3

—

Other disorders of fluid, electrolyte and acid-base balance

21.72

12.62

3.8

5.4

—

Unspecified kidney failure

+∞

12.50

5.6

0.0

—

Disorders of lipoprotein metabolism and other lipidaemias

8.38

12.28

6.0

3.9

—

L04AX Other immunosuppressants

6.00

12.10

5.0

3.3

—

Second line medication for Crohn's disease

6.00

12.10

5.0

3.3

—

Other cataract

8.78

12.00

3.5

5.5

—

Nausea and vomiting

9.84

11.99

2.4

—

Ischemic heart diseases

6.02

11.91

4.5

4.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

5.39

11.83

4.2

3.4

—

Diabetic retinopathy

7.90

11.82

3.3

3.8

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5.50

11.71

2.7

4.2

—

Diabetes, insulin treatment (Kela reimbursement)

5.19

11.51

2.8

4.9

—

Hypertensive Renal Disease

+∞

11.47

5.0

0.0

—

Type 2 diabetes

6.20

11.42

4.3

4.6

—

Autoimmune diseases excluding thyroid diseases

5.19

11.41

4.2

3.3

—

Chronic periapical parodontitis

20.03

11.11

2.6

8.3

—

Gout, idiopatic and unspecified

10.92

11.06

8.1

5.4

—

Disorders of parathyroid gland

24.71

11.05

3.2

2.2

—

Disorders of lens

6.05

11.04

3.3

5.0

—

Viral and other specified intestinal infections

9.78

11.02

2.9

5.2

—

Hyperparathyroidism

27.71

10.65

3.4

2.4

—

Ischaemic heart disease, wide definition

5.76

10.54

3.0

5.0

—

Direct fill therapy

10.02

10.43

2.8

6.6

—

Hernia of abdominal wall, postoperative

+∞

10.42

3.3

0.0

—

Coronary atherosclerosis

6.16

10.35

3.5

—

Dermatitis and eczema

4.28

10.33

4.0

3.7

—

Implicit viral Sepsis

23.37

10.23

2.1

2.5

—

Viral Sepsis

23.37

10.23

2.1

2.5

—

Infections of the skin and subcutaneous tissue

5.10

10.23

3.1

4.8

—

Autoimmune diseases

4.78

10.14

5.0

3.3

—

Complications of medical and surgical care

5.11

10.09

3.3

4.5

—

Used for control exclusion in common control thyroid runs

4.90

10.00

4.6

3.3

—

Diabetic retinopathy, excluding more controls

19.17

9.88

3.6

8.4

—

Chronic periodontitis, including avohilmo

4.80

9.86

2.8

4.8

—

Parodontitis

4.78

9.81

2.8

4.8

—

Parodontitis or operation codes

4.78

9.80

2.8

4.8

—

Care involving use of rehabilitation procedures

24.68

9.54

2.1

5.8

—

General symptoms and signs

5.01

9.45

5.8

3.4

—

Parodontitis and operation codes

4.71

9.42

2.9

4.7

—

Dental caries 1 and operation codes

5.35

9.39

5.4

3.1

—

Ulcer of lower limb, not elsewhere classified

21.71

9.34

2.5

11.7

—

Other diseases of urinary system

4.43

8.80

3.3

4.8

—

COPD/asthma/ILD related infections

5.51

8.73

4.4

4.0

—

COPD/asthma related infections

5.51

8.73

4.4

4.0

—

Viral pneumonia

10.02

8.64

2.2

3.8

—

Gout, strict definition

10.01

8.64

9.4

5.5

—

Other and unspecified dermatitis

6.00

8.64

3.4

3.8

—

Other disorders of urethra and urinary system

6.31

8.62

2.1

5.1

—

Diabetes medication

4.34

8.54

3.6

4.2

—

Dermatitis

5.52

8.48

3.2

3.5

—

Presence of other functional implants

8.37

8.46

2.8

1.6

—

Certain disorders involving the immune mechanism

7.51

8.41

5.4

4.2

—

Bleeding

4.16

8.34

6.0

3.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.33

8.18

3.4

4.5

—

Heart failure and bmi 25plus

8.28

7.63

3.9

2.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.98

7.61

3.4

4.3

—

Gastrointestinal diseases

11.46

7.59

7.4

3.1

—

Other CVD (FINNGEN)

+∞

7.59

4.1

0.0

—

Hard cardiovascular diseases

4.35

7.36

5.0

3.9

—

Charcot foot

+∞

7.30

2.6

0.0

—

IgA nephropathy (IgA glomerulonephritis)

+∞

7.30

5.6

0.0

—

Nutritional anaemias

5.45

7.26

6.6

3.0

—

Gingivitis and periodontal diseases

5.16

7.24

3.4

4.7

—

Persons encountering health services in other circumstances

6.31

7.23

2.6

3.6

—

Iron deficiency anaemia

5.60

6.96

6.9

3.1

—

Acute upper respiratory infections of multiple and unspecified sites

4.50

6.95

6.4

3.6

—

Cutaneous abscess, furuncle and carbuncle

6.00

6.90

4.0

6.3

—

Vitreous haemorrhage

13.78

6.88

5.5

1.9

—

Other disorders of teeth and supporting structures

13.76

6.88

3.8

8.3

—

Dental caries 3 and operation codes

4.18

6.75

5.6

2.9

—

General examination and investigation of persons without complaint and reported diagnosis

4.79

6.49

2.8

3.4

—

Complications of procedures, not elsewhere classified

4.20

6.36

3.3

4.7

—

Molar incisor enamel hypoplasia, with caries

+∞

6.26

3.2

0.0

—

Failure and rejection of transplanted organs and tissues

+∞

6.26

5.7

0.0

—

Bacterial pneumoniae

5.23

6.26

3.2

4.4

—

Dental caries 1

4.60

6.12

6.3

2.9

—

Dental caries 3

4.09

6.00

5.6

2.8

—

Other problems related to primary support group, including family circumstances

12.20

5.98

2.6

4.4

—

Oral corticosteroids

3.50

5.81

6.2

3.1

—

3.63

5.80

4.5

3.2

—

Diseases of the skin and subcutaneous tissue

3.68

5.77

4.6

4.0

—

STROKE

6.36

5.75

3.3

6.3

—

Dentofacial anomalies [including malocclusion]

11.00

5.75

3.0

7.6

—

Dental operations

6.07

5.68

6.1

3.1

—

Other acute lower respiratory infections

3.92

5.65

3.7

4.6

—

Bacterial pneumonia, not elsewhere classified

5.06

5.58

3.3

4.5

—

Disorders of vitreous body and globe

4.53

5.52

4.9

5.2

—

Excluding asthma or asthma-COPD overlap

5.01

5.50

5.8

3.5

—

COPD differential diagnosis

5.01

5.50

5.8

3.5

—

ILD differential diagnosis

5.01

5.50

5.8

3.5

—

Dental caries, including avohilmo

4.35

5.46

6.4

2.9

—

Bronchitis

3.36

5.39

5.0

3.1

—

Peripheral arterial reconstruction

11.26

5.28

2.2

3.0

—

Heart failure and coronary heart disease

6.21

5.28

8.0

4.0

—

Microscopic polyangiitis

+∞

5.23

1.8

0.0

—

Unspecified contracted kidney

+∞

5.23

1.6

0.0

—

Unspecified nephritic syndrome

+∞

5.21

4.0

0.0

—

Myocardial infarction

4.67

5.16

3.8

3.6

—

Cystitis

4.08

5.15

3.8

4.7

—

Diseases of the digestive system

4.18

5.06

3.8

4.8

—

Dental pulpitis 2

4.52

5.03

5.9

2.9

—

Gout, unspecified

10.01

5.02

7.8

2.0

—

Examination and observation for other reasons

4.48

5.00

6.0

3.5

—

Bacterial pneumonia (organism specified)

4.23

5.00

3.2

5.4

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

5.21

4.96

2.6

5.8

—

Disorders of vitreous body

4.35

4.87

5.3

5.2

—

Other pulmonary diagnosis

4.68

4.82

4.6

3.5

—

Other CVD

11.43

4.78

4.1

3.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

4.05

4.75

6.3

3.4

—

Degeneration of macula and posterior pole

5.15

4.62

4.1

2.3

—

Pruritus

14.02

4.57

3.3

2.4

—

Other bacterial intestinal infections

10.01

4.51

3.3

4.8

—

Myocardial infarction, without ST-elevation

4.86

4.51

4.2

5.0

—

Excessive attrition of teeth

5.43

4.50

3.1

6.5

—

Other diseases of intestines

2.79

4.48

2.7

4.6

—

Myocardial infarction, strict

4.72

4.45

4.1

3.2

—

Cardiac arrhythmias

4.85

4.40

3.9

3.1

—

Malaise and fatigue

4.90

4.40

7.9

2.4

—

Acute upper respiratory infections

3.13

4.37

4.7

3.3

—

Parodontitis or/and operation codes

3.37

4.28

2.3

5.4

—

Congenital malformations of the urinary system

11.70

4.27

6.4

2.8

—

Other and unspecified local infections of skin and subcutaneous tissue

11.68

4.27

2.7

8.5

—

Other local infections of skin and subcutaneous tissue

11.68

4.27

2.7

8.5

—

Senile cataract

4.38

4.22

3.3

5.1

—

Tramadol

3.32

4.05

3.2

—

Other disorders of glucose regulation and pancreatic internal secretion

10.02

4.01

2.6

7.7

—

9.76

3.93

1.9

3.7

—

Coronary revascularization (ANGIO or CABG)

4.26

3.93

7.5

3.3

—

Dental caries 3, only avohilmo

3.04

3.92

5.8

2.4

—

Diseases of middle ear and mastoid

3.37

3.90

3.6

4.8

—

9.59

3.89

1.9

3.7

—

Diseases of the eye and adnexa

3.28

3.88

3.6

4.8

—

Dental pulpitis 2, only avohilmo

3.77

3.87

5.9

2.9

—

Bacterial intestinal infections, IBD co-morbidities

7.28

3.85

3.3

7.1

—

Hernia of abdominal wall

3.79

3.80

3.3

4.9

—

Viral pneumonia (unknown virus, not influenza)

12.02

3.76

1.8

9.4

—

Pure hypercholesterolaemia

4.47

3.71

6.1

3.9

—

Dyspnoea

2.89

3.68

5.5

3.5

—

Symptoms and signs involving the digestive system and abdomen

2.78

3.59

7.3

3.3

—

Major coronary heart disease event

3.13

3.54

6.2

3.0

—

Emergency coronary revascularization (for ACS)

3.59

3.52

7.0

3.0

—

Hypothyroidism, strict autoimmune

3.44

3.51

4.9

3.5

—

Cellulitis

5.30

3.50

3.4

6.2

—

Pre-eclampsia

10.01

3.49

6.7

2.3

—

Pre-eclampsia or eclampsia

10.00

3.49

6.7

2.3

—

Diseases of the musculoskeletal system and connective tissue

3.27

3.44

4.3

—

Non-invasive ventilation

9.40

3.36

1.5

5.5

—

Acute suppurative otitis media

4.67

3.16

3.8

6.6

—

Autoimmune diseases related-to ILD

2.66

3.11

4.3

3.9

—

Medical observation and evaluation for suspected diseases and conditions

3.33

3.09

6.6

3.4

—

Oedema, not elsewhere classified

5.80

3.00

2.4

2.8

—

Persons encountering health services for examination and investigation

3.26

2.98

7.8

3.4

—

Erosion of teeth, including avohilmo

7.25

2.98

3.0

8.1

—

Streptococcal septicaemia

10.01

2.98

6.0

3.0

—

Parodontitis, under 40 years and operation codes

10.01

2.98

2.6

5.6

—

Parodontitis, operation under 40 years and operation codes

10.01

2.98

2.6

5.6

—

Parodontitis, under 40 years

10.01

2.98

2.6

5.6

—

Parodontitis, under 40 years, or operation codes

10.01

2.98

2.6

5.6

—

Diseases of the ear and mastoid process

2.42

2.96

4.1

—

Use of pramipexole

5.39

2.86

6.7

5.4

—

Pre-eclampsia or poor fetal growth

6.65

2.86

6.7

2.0

—

Acute sinusitis

3.33

2.85

3.8

—

Disorders of the thyroid gland

2.61

2.83

4.5

4.3

—

Other endocrine disorders

6.43

2.79

3.5

2.0

—

Finngen Rheumatological endpoints

2.55

2.77

5.1

3.6

—

Other diseases of the digestive system

3.91

2.77

5.0

4.8

—

Presence of cardiac and vascular implants and grafts

4.66

2.77

6.5

1.8

—

Abdominal and pelvic pain

2.51

2.75

7.4

3.3

—

Hypoglycaemia, other or unspecified

8.34

2.75

1.8

2.8

—

Iron deficiency anaemia secondary to blood loss (chronic)

6.00

2.69

2.0

2.7

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

6.00

2.69

2.0

3.8

—

Type 1 diabetes, strict (exclude DM2)

5.99

2.69

1.3

7.9

—

Systemic connective tissue disorders

4.21

2.67

1.5

6.3

—

GI-bleeding

3.75

2.67

5.0

—

Substance abuse, excluding more controls

3.01

2.66

6.4

4.5

—

Hypothyroidism, other/unspecified

2.61

2.65

4.5

4.4

—

Oxycodone

4.84

2.65

3.7

2.1

—

Anxiety (asthma-related co-morbidities)

2.87

2.62

3.3

4.2

—

Sequelae with surgical and medical care as external cause

4.67

2.59

4.7

5.5

—

All influenza

4.67

2.59

3.3

4.8

—

Diabetic neuropathy

4.65

2.58

2.9

4.3

—

Sequelae of external causes of morbidity and mortality

4.00

2.56

4.3

5.9

—

Other and unspecified iron deficiency

4.00

2.56

9.9

3.2

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

4.71

2.56

6.1

1.9

—

Osteopathies and chondropathies

2.90

2.55

2.6

4.9

—

Dental pulpitis 1

2.40

2.55

3.1

5.1

—

Diseases of pulp and periapical tissues, including avohilmo

2.40

2.55

3.1

5.1

—

Dental pulpitis 4

2.40

2.55

3.1

5.1

—

Opioids

2.55

7.7

3.1

—

Dental caries 1, only avohilmo

2.56

2.55

6.5

2.6

—

Suppurative and unspecified otitis media

3.63

2.54

3.8

6.2

—

Type 1 diabetes, definitions combined

5.45

2.53

1.3

7.3

—

Symptoms and signs involving the circulatory and respiratory systems

2.32

2.50

7.2

2.8

—

Angina pectoris

3.22

2.49

2.4

3.7

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

0.00

2.48

0.0

4.3

—

Triptan medication for migraine, single purchase ok

0.00

2.48

0.0

4.3

—

Mycoses

3.81

2.46

4.3

5.2

—

Acute bronchitis

2.97

2.43

3.0

4.9

—

Other functional intestinal disorders

2.98

2.43

3.0

4.4

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2.47

2.42

4.5

4.4

—

Non-rheumatic valve diseases

3.89

2.39

1.8

3.6

—

Major coronary heart disease event excluding revascularizations

2.76

2.39

4.0

3.0

—

Open wound of ankle and foot

6.26

2.37

4.0

4.9

—

Sulfonylureas

4.30

2.36

2.4

—

Abnormalities of breathing

2.38

2.33

5.6

2.9

—

Symptoms and signs involving the urinary system

2.46

2.33

4.9

3.9

—

Injury, poisoning and certain other consequences of external causes

2.86

2.30

8.2

4.0

—

Hernia

2.31

2.27

6.8

3.3

—

Headache

3.52

2.24

6.4

2.3

—

Anxiety disorders, excluding more controls

2.53

2.21

1.9

4.4

—

Viral warts

5.56

2.21

2.8

8.8

—

Cardiomyopathy

5.56

2.21

6.0

2.4

—

Phobic anxiety disorders

5.56

2.21

3.6

10.2

—

Anxiety disorders

2.31

2.17

3.0

4.6

—

External causes of morbidity and mortality

2.61

2.15

7.8

3.5

—

Valvular heart disease excluding rheumatic fever

3.44

2.14

1.8

3.5

—

Psychiatric diseases

2.20

2.14

3.3

4.2

—

Anomalies of dental arch relationship, including avohilmo

3.70

2.12

3.1

6.5

—

Dental operations, only avohilmo

2.47

2.12

6.7

3.6

—

COPD (mode)

4.33

2.09

4.8

1.8

—

Parasetamol

2.55

2.09

7.4

3.8

—

Other viral diseases, not elsewhere classified

3.19

2.08

2.3

5.0

—

Diseases of the respiratory system

3.22

2.07

5.8

5.0

—

Other skin changes

5.00

2.07

2.2

2.7

—

Diseases of oesophagus, stomach and duodenum

2.10

2.04

5.2

3.5

—

Other diseases of pleura

2.85

1.99

2.1

4.1

—

Venous thromboembolism

2.82

1.99

2.6

4.8

—

Other viral diseases

2.81

1.99

2.1

5.0

—

All anxiety disorders

2.41

1.96

3.3

4.4

—

Pregnancy hypertension

3.86

1.95

6.7

2.0

—

Asthma, excluding more controls

3.28

1.94

2.5

3.3

—

Unspecified acute lower respiratory infection

4.55

1.94

4.8

9.1

—

Corneal ulcer

3.75

1.93

4.3

5.9

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2.96

1.93

2.5

5.7

—

Other specified/unspecified arthritis

3.75

1.93

5.2

4.2

—

Obesity due to excess calories

2.73

1.93

1.9

5.2

—

Coronary angioplasty

3.36

1.91

11.1

3.6

—

Haemorrhage from respiratory passages

3.25

1.90

6.7

2.3

—

Glucagon-like peptide-1 (GLP-1) analogues

2.74

1.89

1.8

4.6

—

Arthropathies

2.25

1.89

4.7

3.5

—

Viral infections characterized by skin and mucous membrane lesions

2.65

1.86

2.1

5.0

—

Other arthritis (FG)

3.53

1.83

5.2

4.2

—

Substance abuse

2.39

1.83

6.4

4.1

—

Unspecified haematuria

2.86

1.82

5.9

3.0

—

Benign neoplasm of colon, rectum, anus and anal canal

2.68

1.81

2.3

6.6

—

Convulsions, not elsewhere classified

4.12

1.80

4.0

2.8

—

Mental and behavioural disorders due to psychoactive substance use

2.36

1.78

6.4

4.1

—

Coronary artery bypass grafting

4.23

1.77

1.2

4.8

—

Transient ischemic attack

2.76

1.75

1.8

4.6

—

Non-ischemic cardiomyopathy

4.10

1.75

12.8

2.7

—

Benign neoplasm of colon, rectum, anus and anal canal

2.54

1.75

2.3

4.7

—

Umbilical hernia

3.33

1.74

2.7

3.1

—

Keratitis

2.67

1.72

3.8

4.9

—

Injuries to the ankle and foot

2.23

1.72

5.9

3.9

—

Type of accident

2.92

1.72

2.6

6.2

—

Leisure time condition

3.85

1.71

2.4

6.4

—

Pain, not elsewhere classified

3.85

1.71

4.4

2.6

—

Asthma

2.86

1.70

2.5

3.5

—

Neurotic, stress-related and somatoform disorders

2.12

1.70

3.1

4.6

—

Cerebrovascular diseases

2.26

1.69

3.3

4.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

3.00

1.68

2.3

3.2

—

Codeine

2.23

1.67

8.5

3.2

—

Reimbursement for rheumatic diseases

2.38

1.66

1.8

4.5

—

Exposure to unspecified factor

1.97

1.66

2.4

4.2

—

Diagnoses used for exclusion with ILD

3.16

1.66

6.8

4.1

—

DVT of lower extremities and pulmonary embolism

2.79

1.64

2.9

5.1

—

COPD related to multimorbidity

3.16

1.62

4.8

3.3

—

Other and unspecified polyneuropathies, also in other diseases

3.57

1.61

7.0

6.3

—

Ventral hernia

3.57

1.61

4.0

3.2

—

Benign neoplasm: Colon

2.82

1.61

2.4

5.8

—

Other nutritional deficiencies

2.33

1.59

1.8

4.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.71

1.58

6.4

5.2

—

Coxibs

0.00

1.58

0.0

4.4

—

Nonsuppurative otitis media

3.05

1.58

2.8

6.7

—

Fibroblastic disorders

3.33

1.52

1.0

6.3

—

Other diseases of the respiratory system

3.33

1.52

2.2

4.9

—

Other respiratory disorders and diseases

3.33

1.52

2.2

4.9

—

Fracture of foot, except ankle

2.86

1.50

2.7

4.6

—

Ischaemic Stroke, excluding all haemorrhages

2.52

1.50

2.9

4.3

—

Stroke, including SAH

2.31

1.49

3.5

5.5

—

Stroke, excluding SAH

2.48

1.49

2.9

4.3

—

Disorders of sclera, cornea, iris and ciliary body

2.43

1.47

3.4

4.6

—

Syncope and collapse

3.16

1.43

10.6

2.6

—

Inguinal hernia

2.18

1.43

7.6

3.4

—

Obesity

2.29

1.41

1.9

4.8

—

Obesity and other hyperalimentation

2.28

1.41

1.9

4.8

—

Type 2 diabetes, strict (exclude DM1)

2.34

1.41

5.3

4.6

—

Type 2 diabetes, definitions combined

2.33

1.41

5.3

4.6

—

Type 2 diabetes, definitions combined, including avohilmo

2.32

1.40

5.3

4.6

—

COPD, hospital admission 2, with asthma infections

3.05

1.38

5.6

3.6

—

Neoplasms

1.97

1.37

2.2

5.6

—

Retention of urine

3.02

1.36

3.4

3.9

—

Cardiodefibrillation

2.60

1.36

5.2

3.8

—

Polyneuropathies and other disorders of the peripheral nervous system

2.94

1.36

7.0

5.5

—

Other gastritis (incl. Duodenitis)

2.94

1.36

10.8

3.4

—

Otitis externa

2.94

1.36

6.6

5.2

—

Benign neoplasm: Colon

2.36

1.35

2.4

4.6

—

Asthma (only as main-diagnosis), excluding more controls

2.75

1.35

1.5

3.3

—

Sciatica+with lumbago

0.00

1.34

0.0

4.8

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.14

1.32

3.0

4.6

—

Irregular menses

2.90

1.30

2.8

3.8

—

Congenital malformations, deformations and chromosomal abnormalities

2.03

1.30

4.5

3.9

—

Primary_lymphoid and hematopoietic malignant neoplasms

2.78

1.28

2.0

5.2

—

Recurrent or chronic depression

2.55

1.28

3.2

5.7

—

Other neurological diseases

2.12

1.27

2.4

4.4

—

Any mental disorder

1.82

1.25

3.5

4.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

2.40

1.24

2.5

5.1

—

Other and unspecified tonsillitis

2.42

1.23

2.5

4.7

—

Sensorineural hearing loss

2.03

1.23

2.5

4.9

—

Abnormal findings on examination of blood, without diagnosis

2.20

1.23

3.3

5.0

—

Mood disorders, excluding more controls

1.97

1.22

2.2

4.2

—

Other diseases of anus and rectum

2.63

1.21

2.4

6.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.73

1.19

2.0

3.4

—

Mental and behavioural disorders due to alcohol

2.10

1.18

7.6

4.3

—

Other/unspecified dorsalgia

2.30

1.18

3.3

5.3

—

Gonarthrosis, primary, with knee surgery

0.00

1.17

0.0

3.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.97

1.15

3.9

4.7

—

Primary_lymphoid and hematopoietic malignant neoplasms

2.50

1.15

2.0

5.2

—

Pulmonary heart disease, diseases of pulmonary circulation

2.50

1.15

1.6

5.0

—

Infections with a predominantly sexual mode of transmission

2.50

1.15

3.0

6.5

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2.39

1.13

2.3

5.7

—

Chronic lower respiratory diseases

1.68

1.13

3.0

4.2

—

Atopic dermatitis

2.01

1.11

5.9

3.3

—

Retinal detachments and breaks

2.38

1.09

2.4

4.7

—

Disorders of synovium and tendon

2.17

1.07

2.7

4.5

—

Diseases of male genital organs

1.90

1.07

2.0

4.4

—

Constipation

1.79

1.06

2.5

4.4

—

Conductive and sensorineural hearing loss

1.90

1.06

2.5

4.8

—

Sequelae of cerebrovascular disease

2.31

1.04

5.6

5.3

—

Organic, including symptomatic, mental disorders

2.11

1.03

3.9

4.5

—

Exclusions for E4_PCOS_BROAD

2.27

1.03

3.8

5.4

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2.06

1.02

7.4

4.4

—

1.92

1.02

6.9

3.9

—

Hyperplasia of prostate

2.10

1.02

5.0

5.5

—

Shoulder lesions

1.90

1.00

4.7

4.2

—

Rotator cuff syndrome

2.00

0.98

2.6

4.3

—

Pain in limb

1.90

0.98

4.1

3.8

—

Other disorders of lacrimal gland

2.17

0.98

2.0

5.4

—

Asthma (only as main-diagnosis)

2.41

0.97

1.5

3.5

—

1.79

0.95

6.9

4.0

—

COPD, hospital admissions

2.31

0.95

4.8

4.4

—

COPD, early/later onset

2.30

0.95

4.8

4.4

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.26

0.94

1.7

3.4

—

Atopic dermatitis, strict definition with reimbursement

2.24

0.93

7.3

3.8

—

Disorders of refraction and accommodation

2.21

0.93

2.0

5.2

—

Disorders of gallbladder, biliary tract and pancreas

1.71

0.92

5.2

3.8

—

Codeine or tramadol medication

1.69

0.92

8.9

2.8

—

Asthma (mode)

2.20

0.92

1.2

3.5

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.14

0.91

1.7

4.9

—

Conjunctivitis (acute, non atopic)

2.14

0.91

2.5

5.0

—

Atopic dermatitis, strict definition

2.10

0.90

7.3

3.9

—

Polycystic ovarian syndrome, consortium definition

2.13

0.90

2.5

3.5

—

Other chronic obstructive pulmonary disease

2.08

0.89

4.8

4.1

—

COPD

2.06

0.88

4.8

4.1

—

Pain (limb, back, neck, head abdominally)

1.71

0.88

7.8

2.7

—

Alcohol use disorder, Swedish definition

1.90

0.88

6.6

4.1

—

Asthma/COPD (KELA code 203)

1.67

0.86

2.3

4.3

—

Other specific joint derangements/joint disorders

1.85

0.86

7.4

3.8

—

Paracetamol of NSAID medication

0.00

0.83

0.0

3.7

—

Depression

1.69

0.83

2.2

4.8

—

Asthma-related infections

1.75

0.83

2.8

4.4

—

Asthma, hospital admission 2, infections

1.75

0.83

2.8

4.4

—

Fenamates

0.00

0.81

0.0

4.6

—

Asthma-related pneumonia

1.87

0.81

3.5

4.6

—

Asthma, hospital admissions 3, pneumonia

1.87

0.81

3.5

4.6

—

Asthma-related pneumonia or sepsis

1.87

0.81

3.5

4.6

—

Obesity, other/unspecified

0.00

0.79

0.0

5.8

—

Other fall from one level to another

0.00

0.79

0.0

5.0

—

Benign lipomatous neoplasm

0.00

0.78

0.0

5.1

—

Other disorders of veins

0.00

0.78

0.0

5.2

—

Symptoms and signs involving the skin and subcutaneous tissue

1.66

0.78

1.8

4.3

—

Malignant neoplasm of skin

1.81

0.77

1.7

3.1

—

Disorders of skin appendages

1.76

0.76

2.0

4.9

—

Soft tissue disorders

1.58

0.74

4.2

3.8

—

Exclusions for E4_PCOS_CONSORTIUM

1.66

0.74

1.3

4.7

—

Urticaria

2.00

0.72

1.4

5.3

—

Basal cell carcinoma

1.99

0.72

2.0

3.3

—

Basal cell carcinoma, including avohilmo

1.97

0.71

2.0

3.4

—

Unspecified fall

1.74

0.70

2.9

4.6

—

Other and unspecified effects of external causes

1.92

0.70

2.8

5.2

—

Diseases of liver

1.92

0.70

2.4

5.5

—

Disorders of lacrimal system

1.92

0.70

2.0

5.0

—

Abnormal findings on diagnostic imaging of lung

1.80

0.66

1.4

5.0

—

Leiomyoma of uterus

1.78

0.64

1.2

4.1

—

Urticaria and erythema

1.72

0.64

1.4

4.8

—

Dizziness and giddiness

1.66

0.63

3.8

4.7

—

Diseases of external ear

1.67

0.61

6.6

4.3

—

Other degenerative diseases of the nervous system

0.00

0.61

0.0

4.8

—

Injuries to the neck

0.00

0.60

0.0

5.9

—

Disturbances of skin sensation

0.00

0.60

0.0

5.7

—

Pollen allergy

0.00

0.60

0.0

6.1

—

Use of hypnotics and sedatives

1.50

0.60

3.2

4.4

—

Lyme disease

0.00

0.59

0.0

5.5

—

Other spirochaetal diseases

0.00

0.59

0.0

5.5

—

Selective serotonin reuptake inhibitors

0.55

0.59

6.0

4.3

—

Mood [affective] disorders

1.52

0.59

2.2

4.6

—

Mood disorders

1.52

0.58

2.2

4.6

—

Personality disorders

0.00

0.58

0.0

6.0

—

Transport accidents

1.72

0.57

8.2

5.0

—

Other chronic obstructive pulmonary disease, including avohilmo

1.66

0.56

4.8

3.8

—

Persons with potential health hazards related to communicable diseases

1.57

0.54

4.5

4.7

—

Falls/tendency to fall

1.41

0.53

4.9

3.8

—

Fracture of lower leg, including ankle

1.53

0.52

2.2

5.6

—

Injuries to the shoulder and upper arm

1.52

0.52

2.8

4.4

—

1.49

0.51

3.2

4.5

—

Diverticular disease of intestine

1.60

0.50

2.1

5.9

—

Injuries to the elbow and forearm

1.47

0.47

2.0

4.6

—

Neurological diseases

1.44

0.46

5.3

3.6

—

Other disorders of ear

1.44

0.44

2.7

4.3

—

Other arthrosis

1.63

0.43

1.6

4.0

—

Delivery, wide proxy

0.00

0.43

0.0

1.9

—

Antenatal screening

0.00

0.43

0.0

1.6

—

Supervision of normal pregnancy

0.00

0.43

0.0

1.6

—

Any dementia

0.00

0.42

0.0

3.0

—

Alzheimer disease, including avohilmo

0.00

0.42

0.0

3.0

—

Fracture of shoulder and upper arm

1.56

0.42

3.0

4.9

—

Alcohol use disorder, ICD-based

1.52

0.41

6.0

5.0

—

Hyperkinetic disorders

0.00

0.41

0.0

7.5

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.41

0.0

3.3

—

Cervicalgia

0.00

0.41

0.0

5.4

—

Congenital malformations of cardiac septa

0.00

0.41

0.0

5.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.40

0.0

6.2

—

Personality disorders, excluding more controls

0.00

0.40

0.0

6.4

—

Injuries to the thorax

1.47

0.40

8.8

4.0

—

Migraine

1.47

0.40

2.0

4.2

—

Schizophrenia

0.00

0.40

0.0

6.4

—

Subjective visual disturbances

0.00

0.40

0.0

5.9

—

Benign lipomatous neoplasm

0.00

0.40

0.0

6.2

—

Visual disturbances

1.43

0.39

1.4

4.5

—

Nasal polyp

0.00

0.39

0.0

4.2

—

Enthesopathies of lower limb, excluding foot

0.00

0.39

0.0

5.5

—

Glaucoma

1.42

0.39

1.8

4.6

—

Visual disturbances and blindness

1.39

0.38

1.4

4.4

—

Other anxiety disorders

1.39

0.38

2.8

4.9

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.40

0.36

3.4

4.2

—

Accidents

1.37

0.36

5.0

4.3

—

Other external causes of accidental injury

1.37

0.36

5.0

4.3

—

Other soft tissue disorders, not elsewhere classified

1.40

0.36

4.0

3.9

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.35

0.34

2.0

4.3

—

Injuries to the wrist and hand

0.67

0.33

2.5

4.1

—

Intracranial trauma

1.32

0.33

10.0

3.5

—

Pain in joint

1.32

0.31

8.1

2.6

—

Dental pulpitis 1, only avohilmo

1.31

0.29

3.5

4.5

—

Dental pulpitis 4, only avohilmo

1.31

0.29

3.5

4.5

—

Dental caries 2 and operation codes

1.30

0.28

2.0

4.5

—

Dental caries 2

1.28

0.28

2.0

4.5

—

Disorders of eyelid, lacrimal system and orbit

1.28

0.28

2.8

4.0

—

Chronic diseases of tonsils and adenoids

1.19

0.25

3.2

3.6

—

Other antidepressants

1.28

0.23

3.6

4.4

—

Concussion

1.27

0.22

11.8

3.5

—

Postmenopausal bleeding

0.00

0.22

0.0

2.2

—

Procreative management

1.24

0.22

2.8

4.6

—

Outcome of delivery

0.00

0.22

0.0

1.4

—

Single delivery by caesarean section

0.00

0.22

0.0

1.4

—

Alzheimer disease, excluding more controls

0.00

0.22

0.0

3.3

—

Pregnancy, childbirth and the puerperium

0.00

0.22

0.0

1.7

—

Mouth breathing

1.22

0.22

1.6

5.0

—

Noninfective enteritis and colitis

1.22

0.22

2.2

4.5

—

Dysplasia of cervi uteri

0.00

0.22

0.0

4.4

—

Use of other anti-dementia drugs

0.00

0.21

0.0

3.3

—

Use of memantine

0.00

0.21

0.0

3.3

—

Long labour

0.00

0.21

0.0

2.8

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.9

—

Medical treatment for female infertility

0.00

0.21

0.0

4.1

—

Disorders of muscles

0.00

0.21

0.0

7.4

—

Achilles tendinitis

0.00

0.21

0.0

7.2

—

Other sleep disorders

0.00

0.21

0.0

3.7

—

Acute and transient psychotic disorders

0.00

0.21

0.0

7.5

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.21

0.0

7.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.21

0.0

3.9

—

Recurring oral aphthae, including avohilmo

0.00

0.21

0.0

5.7

—

Mucosal proctocolitis

0.00

0.21

0.0

9.2

—

Hallux rigidus

0.00

0.21

0.0

2.0

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.21

0.0

4.0

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.21

0.0

4.1

—

Complications predominantly related to the puerperium

0.00

0.21

0.0

3.9

—

All dysplastic lesions of the cervix uteri

0.00

0.21

0.0

4.2

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

0.21

0.0

6.9

—

FESS (DNB20)

0.00

0.21

0.0

6.5

—

Lateral epicondylitis

0.00

0.21

0.0

6.5

—

Dislocation, sprain and strain of joints and ligaments at neck level

0.00

0.21

0.0

8.0

—

Somatoform disorder

0.00

0.21

0.0

8.3

—

Lichen planus, including avohilmo

0.00

0.21

0.0

3.5

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

3.6

—

Disturbance of activity and attention

0.00

0.21

0.0

8.8

—

Other (not insulin) diabetes medications

1.29

0.21

4.7

4.6

—

False labour

0.00

0.21

0.0

1.8

—

Crohn disease

0.00

0.21

0.0

7.6

—

Pain in thoracic spine

0.00

0.21

0.0

6.2

—

Supervision of high-risk pregnancy

0.00

0.20

0.0

1.6

—

Any dementia, excluding more controls

0.00

0.20

0.0

2.9

—

Asthma, including avohilmo

0.79

0.20

2.3

4.2

—

Alzheimer disease

0.00

0.20

0.0

3.0

—

Degenerative diseases of the nervous system

0.00

0.20

0.0

3.0

—

Appendectomy

1.26

0.20

2.0

4.5

—

Ethmoidectomy

0.00

0.20

0.0

5.8

—

Radiculopathy

0.00

0.20

0.0

6.6

—

Spondylolisthesis/Spondylolysis

0.00

0.20

0.0

6.0

—

Septal defects

0.00

0.20

0.0

2.9

—

Injuries to the knee and lower leg

1.23

0.20

2.3

4.4

—

Depression or dysthymia

1.16

0.19

3.0

4.3

—

Gastro-oesophageal reflux disease

1.13

0.18

5.2

3.7

—

Sleep disorders (combined)

1.24

0.18

5.5

4.0

—

Tonsillectomy and adenotomy

1.13

0.17

2.1

4.7

—

Spondylopathies

0.72

0.17

1.2

4.5

—

Disorders of conjunctiva

1.12

0.16

2.3

4.1

—

Malignant neoplasm

1.11

0.15

2.2

4.5

—

Benzodiazepine use

1.12

0.15

6.2

3.8

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1.11

0.15

2.2

4.5

—

Malignant neoplasm, wide definition for exclusion

1.11

0.15

2.2

4.5

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1.11

0.15

2.2

4.5

—

Sleep apnoea, including avohilmo

1.10

0.15

5.4

3.9

—

Nerve, nerve root and plexus disorders

1.19

0.12

4.5

3.9

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.09

0.09

1.8

4.3

—

Cholelithiasis

1.08

0.09

6.8

3.7

—

Other joint disorders

0.81

0.08

6.4

3.6

—

Persons encountering health services in circumstances related to reproduction

0.77

0.08

3.0

4.0

—

Benign neoplasms

1.04

0.08

1.7

5.7

—

Conjunctivitis

1.05

0.08

2.3

4.1

—

Biguanides

0.84

0.08

4.7

4.2

—

Other intervertebral disc disorders

0.83

0.08

1.5

4.3

—

Benign neoplasms

1.14

0.07

2.4

4.9

—

Any event in cancer register

0.85

0.07

2.3

4.6

—

Sleep apnoea

1.02

0.07

5.8

3.9

—

Dorsalgia

1.13

0.06

4.3

4.5

—

Episodal and paroxysmal disorders

0.93

0.01

5.1

3.7

—

Injuries to the head

0.94

0.00

6.4

3.5

—

Dorsopathies

1.02

0.00

3.6

4.4

—

Other diseases of upper respiratory tract

0.97

0.00

6.4

3.4

—

Fall on same level

0.96

0.00

5.7

3.6

—

Other dorsopathies, not elsewhere classified

1.05

0.00

3.7

4.4

—

Adalimumab

0.00

0.0

11.1

—

Benign neoplasm: Stomach

0.00

0.0

1.8

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

0.00

0.0

2.3

—

Hyperkinetic disorders, excluding more controls

0.00

0.0

11.4

—

Embedded teeth, including avohilmo

0.00

0.0

9.6

—

Weight loss

0.00

0.0

3.3

—

Brachial plexus disorders

0.00

0.0

4.5

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

0.0

9.3

—

malignant neoplasm of female genital organs

0.00

0.0

2.0

—

Benign neoplasm of bone and articular cartilage

0.00

0.0

8.0

—

Mental disorders, not otherwise specified

0.00

0.0

9.6

—

Sequelae of injuries of upper limb

0.00

0.0

10.0

—

Abnormal involuntary movements

0.00

0.0

4.8

—

Bitten or struck by other mammals

0.00

0.0

6.6

—

Budesonide

0.00

0.0

1.8

—

Other disorders of the genitourinary system

0.00

0.0

2.0

—

L02BA Anti-estrogens

0.00

0.0

2.3

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.0

4.6

—

Chalazion

0.00

0.0

7.9

—

Olecranon bursitis

0.00

0.0

8.9

—

Other bursopathies

0.00

0.0

8.1

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.0

9.4

—

Parkinson's disease, strict definition

0.00

0.0

3.1

—

Suggestive for eosinophilic asthma

0.00

0.0

5.5

—

Other hammer toe(s) (acquired)

0.00

0.0

2.1

—

Other female pelvic inflammatory diseases

0.00

0.0

2.3

—

Graves disease, strict definition

0.00

0.0

6.0

—

Cholelithiasis, broad definition with cholecystitis

0.88

0.00

7.6

3.7

—

Crohn's disease of small intestine

0.00

0.0

6.4

—

L02BB Anti-androgens

0.00

0.0

2.7

—

Malignant neoplasm of head and neck

0.00

0.0

5.7

—

Pleural plaque

0.00

0.0

3.0

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.0

9.6

—

Appendicitis, broad definition

0.88

0.00

1.8

4.6

—

Alzheimer’s disease (Late onset)

0.00

0.0

3.8

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

0.0

8.3

—

Mixed and other personality disorders

0.00

0.0

9.9

—

Abnormal weight loss

0.00

0.0

3.2

—

Divergent concomitant strabismus

0.00

0.0

4.9

—

Otitis externa, unspecified

0.00

0.0

7.4

—

Lichen planus

0.00

0.0

2.4

—

Benign mammary dysplasia

0.00

0.0

4.6

—

Lung cancer and mesothelioma

0.00

0.0

1.9

—

Infections of genitourinary tract in pregnancy

0.00

0.0

5.8

—

Benign neoplasm of bone and articular cartilage

0.00

0.0

2.4

—

Benign neoplasm: Caecum

0.00

0.0

2.4

—

Emotional disorders starting during childhood or adolescence

0.00

0.0

2.7

—

Other inflammatory liver diseases

0.00

0.0

2.8

—

Exposure to other and unspecified inanimate mechanical forces

0.00

0.0

8.5

—

Inflammatory diseases of the central nervous system

0.00

0.0

9.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

0.00

0.0

4.4

—

Congenital malformations of eye, ear, face and neck

0.00

0.0

3.4

—

Focal brain injury

0.00

0.0

5.1

—

Alzheimer’s disease, wide definition

0.00

0.0

3.7

—

Disorders of optic nerve and visual pathways

0.00

0.0

2.0

—

Other embolism and thrombosis

0.00

0.0

11.0

—

Other inflammation of eyelid

0.00

0.0

2.1

—

Crossbite

0.00

0.0

2.4

—

Scoliosis

0.00

0.0

2.7

—

Alzheimer’s disease, wide definition, excluding more controls

0.00

0.0

3.5

—

Asthma (diagnoses ohter than nonallergic)

0.92

0.00

2.6

4.0

—

Intracerebral haemorrhage

0.00

0.0

4.0

—

HSIL lesion of the cervix uteri

0.00

0.0

5.0

—

Heterophoria

0.00

0.0

2.4

—

Unspecified lump in breast

0.00

0.0

4.5

—

Varicose veins of other sites

0.00

0.0

9.4

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

0.00

0.0

5.3

—

Follow-up examination after treatment for malignant neoplasms

0.00

0.0

1.6

—

Diseases of salivary glands

0.00

0.0

8.3

—

Cervicocranial syndrome

0.00

0.0

2.4

—

Emotionally unstable personality disorder

0.00

0.0

10.6

—

Flat foot [pes planus] (acquired)

0.00

0.0

2.6

—

Non-small cell lung cancer

0.00

0.0

3.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.98

0.00

2.6

4.2

—

Benign neoplasm of breast

0.00

0.0

5.2

—

Valvular operations

0.00

0.0

3.1

—

Other appendicitis

0.00

0.0

9.0

—

Endometriosis of rectovaginal septum and vagina

0.00

0.0

5.8

—

MS-disease / Multiple Sclerosis

0.00

0.0

5.8

—

LSIL lesion of the cervix uteri

0.00

0.0

5.7

—

Other sexually transmitted chlamydial diseases

0.00

0.0

13.8

—

Benign neoplasm: Caecum

0.00

0.0

1.8

—

Impacted cerumen

0.00

0.0

2.9

—

Postpartum haemorrhage due to retained placenta

0.00

0.0

5.6

—

Lumbar disc prolapse

0.90

0.00

1.6

4.3

—

Left ventricular outflow tract obstruction, narrow definition

0.00

0.0

3.2

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

0.0

3.0

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

0.00

0.0

2.6

—

Parkinson's disease, including avohilmo

0.00

0.0

3.0

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

0.00

0.0

2.5

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.0

8.6

—

Demyelinating diseases of the central nervous system

0.00

0.0

5.0

—

Exposure to other specified factors

0.97

0.00

2.2

4.3

—

Foreign body or object entering through skin

0.00

0.0

11.5

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.0

1.7

—

Other noninflammatory disorders of vagina

0.00

0.0

5.8

—

Vocal cord dysfunction

0.00

0.0

5.2

—

Other benign neoplasms of connective and other soft tissue

0.00

0.0

8.2

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

0.00

0.0

5.7

—

Benign neoplasm of breast

0.00

0.0

5.2

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.0

8.0

—

Diseases of appendix

0.86

0.00

1.8

4.6

—

Parkinson's disease

0.00

0.0

3.0

—

Sequelae of infectious and parasitic diseases

0.00

0.0

12.8

—

Contact with other sharp object(s)

0.00

0.0

9.5

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.0

3.0

—

Endometriosis ASRM stages 1,2

0.00

0.0

5.7

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.0

6.2

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

0.0

2.3

—

Salpingitis and oophoritis

0.00

0.0

2.1

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.0

8.2

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.0

2.1

—

Haemangioma and lymphangioma, any site

0.00

0.0

3.0

—

Colon adenocarcinoma

0.00

0.0

2.4

—

Haemangioma, any site

0.00

0.0

3.0

—

Liveborn infants according to place of birth

0.00

0.0

2.2

—

Injury of muscle and tendon at hip and thigh level

0.00

0.0

9.0

—

Superficial injury of hip and thigh

0.00

0.0

1.9

—

Malignant melanoma of skin

0.00

0.0

2.2

—

Schizoaffective disorder

0.00

0.0

10.0

—

Malignant melanoma

0.00

0.0

2.0

—

Benign neoplasm of ovary

0.00

0.0

2.1

—

Hypertrophy of breast

0.00

0.0

5.0

—

Endometriosis of pelvic peritoneum

0.00

0.0

4.6

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

0.0

11.5

—

Parkinson's disease, excluding more controls

0.00

0.0

3.8

—

Allergic contact dermatitis

0.00

0.0

7.7

—

Malignant neoplasm of colon

0.00

0.0

3.1

—

Pregnancy examination and test

0.00

0.0

1.5

—

Malignant neoplasm of bronchus and lung

0.00

0.0

3.0

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.0

1.8

—

Single delivery by forceps and vacuum extractor

0.00

0.0

1.2

—

0.00

0.0

1.6

—

Other benign neoplasms of connective and other soft tissue

0.00

0.0

7.7

—

Atrial septal defect

0.00

0.0

3.1

—

Cholecystitis

0.00

0.0

2.8

—

Acute appendicitis

0.91

0.00

1.8

4.6

—

Benign neoplasm of meninges

0.00

0.0

1.8

—

Benign neoplasm of ovary

0.00

0.0

5.2

—

Malignant neoplasm of breast, HER-negative

0.00

0.0

2.5

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.0

5.7

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.0

4.0

—

Other noninflammatory disorders of vulva and perineum

0.00

0.0

5.8

—

Multiple delivery

0.00

0.0

2.0

—

Puerperal sepsis

0.00

0.0

5.7

—

Other disorders originating in the perinatal period

0.00

0.0

2.5

—

Disorders of continuity of bone

0.00

0.0

5.5

—

Hypertrophy of breast in women and men

0.00

0.0

4.3

—

Inflammatory disease of uterus

0.00

0.0

2.8

—

Trochanteric bursitis

0.00

0.0

2.0

—

Thoracic aortic aneurysm

0.00

0.0

12.0

—

Other disorders of breast

0.00

0.0

5.7

—

Uterine polyps

0.00

0.0

5.8

—

Unspecified/other endometriosis

0.00

0.0

6.0

—

Asthma, hospital admissions , main diagnosis only

1.01

0.00

1.4

4.2

—

Other specified and unspecified personality disorders

0.00

0.0

11.4

—

Benign neoplasm of major salivary glands

0.00

0.0

1.8

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

2.3

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cell count and Differential panel - Peritoneal dialysis fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS